Developing a Classification of Hematologic Neoplasms in the Era of Precision Medicine.
Sign Up to like & getrecommendations! Published in 2022 at "Blood"
DOI: 10.1182/blood.2022015849
Abstract: The recently developed International Consensus (IC) classification of hematologic neoplasms is primarily based on input from clinical advisory committees composed of pathologists, hematologists, oncologists, and genomic scientists. Morphology continues to represent a fundamental element in… read more here.
Keywords: classification; classification hematologic; hematologic neoplasms; medicine ... See more keywords
Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing.
Sign Up to like & getrecommendations! Published in 2020 at "Blood advances"
DOI: 10.1182/bloodadvances.2020002306
Abstract: Findings support use of PB samples for chronic myeloid neoplasms and for acute leukemias with sufficient circulating disease. In acute leukemias, BM appears to be superior to PB for monitoring measurable residual disease, even in… read more here.
Keywords: hematologic neoplasms; 164 paired; mutational analysis; analysis hematologic ... See more keywords
EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2024.1320689
Abstract: During lymphocyte development, a diverse repertoire of lymphocyte antigen receptors is produced to battle against pathogens, which is the basis of adaptive immunity. The diversity of the lymphocyte antigen receptors arises primarily from recombination-activated gene… read more here.
Keywords: ebf1 pax5; hematologic neoplasms; cell development; cell ... See more keywords
Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14246080
Abstract: Simple Summary Hematologic neoplasms comprise a heterogeneous group of diseases that interfere with normal blood production. Treating patients who fail available therapies for these diseases is an ongoing challenge. Thus, the search for new treatment… read more here.
Keywords: effects eribulin; hematologic neoplasms; cellular molecular; blood ... See more keywords